Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Gapping up/down: BIG +5% and MRVL +3% after earnings, EU banks showing early strength; BBG -9%, WING -7%, FSTR -7%, COST -4% and ADSK -2% after earnings<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>HABT</strong> +15.9%, <strong>BIG</strong> +5.3%, <strong>SNDX</strong> +3.9%, <strong>MRVL</strong> +3.3%, <strong>SYN</strong> +3.1%, <strong>EVC</strong> +2.7%, <strong>GWRE</strong> +2.4%, <strong>ABR</strong> +1.2%, <strong>SPKE</strong> +1.1%</li></ul><p><strong>Select EU financial related names showing strength</strong>:</p><ul><li><strong>ING</strong> +4.4%, <strong>BBVA</strong> +4%, <strong>DB</strong> +3.3%, <strong>CS</strong> +3.3%, <strong>SAN</strong> +2.4%</li></ul><p><strong>Select metals/mining stocks trading higher</strong>:</p><ul><li><strong>VALE</strong> +5.4%, <strong>GFI</strong> +2.8%, <strong>BBL</strong> +1.8%, <strong>BHP</strong> +1.7%, <strong>CLF</strong> +1.7%, <strong>RIO</strong> +1.5%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>BIOS</strong> +6.8% (enters into a Stock Purchase Agreement for the sale of an aggregate of 3,300,000 shares of its common stock for aggregate gross proceeds of $5,070,780 in a private placement)</li><li><strong>PPHM</strong> +6.2% (indicated higher after Ronin Capital discloses 6.8% active stake; may also wish to engage in a dialogue with officers, directors, and other representatives )</li><li><strong>VTTI</strong> +3.5% (VTTI Energy Partners receives a proposal from VTTI B.V. pursuant to which VTTI would acquire through a wholly owned subsidiary all publicly held common units of the Partnership in exchange for $18.75/unit )</li><li><strong>OCLR</strong> +3.5% (continued strength)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>ADSW</strong> +1.7% (upgraded to Buy at BofA/Merrill)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>IMMR</strong> -19.7%, <strong>NTNX</strong> -19.2%, <strong>BBG</strong> -9.4%, <strong>CGG</strong> -7%, <strong>WING</strong> -6.8%, <strong>FSTR</strong> -6.6%</li><li><strong>AOBC</strong> -5.1%, <strong>RGLS</strong> -4.5%, <strong>AMRS</strong> -4.5%,</li><li><strong>COST</strong> -4.3%, (Costco also confirmed plans for membership fee increase ), <strong>ADSK</strong> -1.7%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>SCYX</strong> -22.6% (delays the initiation of any new clinical studies with the IV formulation of SCY-078 until the FDA completes a review of all available pre-clinical and clinical data of the IV formulation of SCY-078)</li><li><strong>KPTI</strong> -15.1% (announced the results of a planned interim analysis of the Phase 2 SOPRA study evaluating single agent selinexor in relapsed/refractory acute myeloid leukemia; study will not reach statistically significant improvement in primary endpoint of overall survival in patients who are unfit for chemotherapy and/or transplantation )</li><li><strong>HMSY</strong> -10.5% ( files to delay its 10-K; is continuing to evaluate whether this issue affects its consolidated financial results, primarily focusing on prior periods in which revenue relating to the CMS business was recorded)</li><li><strong>ZSAN</strong> -9.7% ( files for $46 mln common stock offering)</li><li><strong>BLDR</strong> -1.5% (commences a secondary offering of 10,000,000 shares of its common stock to be sold by JLL Building Holdings)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>KITE</strong> -1.5% (downgraded to Hold at Stifel)</li><li><strong>CIEN</strong> -1.5% (downgraded to Neurtral at BofA/Merrill)</li></ul></td> </tr></table>"